Vanguard Capital Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44M Sell
2,412,651
-48,151
-2% -$960K ﹤0.01% 1958
2026
Q2
$55.6M Buy
2,460,802
+61,735
+3% +$1.55M ﹤0.01% 1883
2026
Q1
$60M Buy
+2,399,067
New +$67.6M ﹤0.01% 1761

Other funds holding PRCT

Vanguard Capital Management's PRCT Position: Q3 2026 in Review

Vanguard Capital Management reduced its Procept Biorobotics (PRCT) stake by 2% in Q3 2026, selling an estimated $960K and leaving 2,412,651 shares worth $44M. The position accounts for ﹤0.01% of the portfolio, ranked #1958.

Vanguard Capital Management first reported a position in PRCT in Q1 2026 and has held it in 3 quarters since. The position peaked at $60M in Q1 2026. 229 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Vanguard Capital Management held 2,412,651 shares of Procept Biorobotics worth $44M as of Q3 2026.
  • Vanguard Capital Management sold 48,151 Procept Biorobotics shares in Q3 2026, an estimated $960K.
  • Procept Biorobotics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1958 holding.
  • Vanguard Capital Management first reported a position in Procept Biorobotics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Procept Biorobotics position peaked at $60M in Q1 2026.
  • 229 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.